Subtopic Deep Dive

Emergency Contraception Effectiveness
Research Guide

What is Emergency Contraception Effectiveness?

Emergency Contraception Effectiveness evaluates the efficacy of levonorgestrel and ulipristal acetate in preventing pregnancy after unprotected intercourse, focusing on timing, BMI effects, and ovulation inhibition mechanisms.

Key studies compare levonorgestrel regimens against Yuzpe (Task Force on Postovulatory Methods of Fertility, 1998, 731 citations) and ulipristal (Glasier et al., 2010, 517 citations). WHO trials assess low-dose mifepristone and levonorgestrel dosing (von Hertzen et al., 2002, 570 citations). U.S. guidelines provide eligibility criteria (Curtis et al., 2016, 1442 citations) and practice recommendations (Curtis et al., 2016, 755 citations). Over 20 papers from the list address real-world use and trends.

15
Curated Papers
3
Key Challenges

Why It Matters

Emergency contraception reduces unintended pregnancy rates, lowering abortion incidence as shown in adolescent trends (Sedgh et al., 2015, 796 citations). U.S. MEC guidelines enable safe access for women with medical conditions (Curtis et al., 2016). UK Natsal-3 survey links it to unplanned pregnancy prevalence (Wellings et al., 2013, 477 citations), informing public health policies. Effectiveness data guide BMI-adjusted regimens, impacting global reproductive health access.

Key Research Challenges

Timing Window Variability

Effectiveness drops beyond 72 hours for levonorgestrel versus 120 hours for ulipristal (Glasier et al., 2010). Real-world delays reduce efficacy in surveys (Wellings et al., 2013). Studies need precise ovulation inhibition models.

BMI Impact on Efficacy

Higher BMI lowers levonorgestrel effectiveness, per U.S. criteria (Curtis et al., 2016). Ulipristal shows better performance across weights (Glasier et al., 2010). Trials lack diverse population data.

Real-World Adherence Gaps

Usage rates remain low despite availability (Bachrach and Mosher, 1984; Sedgh et al., 2015). Behavioral factors affect timely access (Wellings et al., 2013). RCT data overestimate field efficacy.

Essential Papers

1.

U.S. Medical Eligibility Criteria for Contraceptive Use, 2016

Kathryn M. Curtis, Naomi K. Tepper, Tara C. Jatlaoui et al. · 2016 · MMWR Recommendations and Reports · 1.4K citations

The 2016 U.S. Medical Eligibility Criteria for Contraceptive Use (U.S. MEC) comprises recommendations for the use of specific contraceptive methods by women and men who have certain characteristics...

2.

Adolescent Pregnancy, Birth, and Abortion Rates Across Countries: Levels and Recent Trends

Gilda Sedgh, Lawrence B. Finer, Akinrinola Bankole et al. · 2015 · Journal of Adolescent Health · 796 citations

3.

U.S. Selected Practice Recommendations for Contraceptive Use, 2016

Kathryn M. Curtis, Tara C. Jatlaoui, Naomi K. Tepper et al. · 2016 · MMWR Recommendations and Reports · 755 citations

The 2016 U.S. Selected Practice Recommendations for Contraceptive Use (U.S. SPR) addresses a select group of common, yet sometimes controversial or complex, issues regarding initiation and use of s...

4.

Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception

Regulation, Task Force on Postovulatory Methods of Fertility · 1998 · The Lancet · 731 citations

5.

Use of Contraception in the United States, 1982

Christine A. Bachrach, William D. Mosher · 1984 · PsycEXTRA Dataset · 688 citations

More than 99% of women 15-44 years of age who have ever had sexual intercourse with a male (referred to as "sexually experienced women") have used at least one contraceptive method. The percentage ...

6.

Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial

Helena von Hertzen, Gilda Piaggio, Alexandre Peregoudov et al. · 2002 · The Lancet · 570 citations

7.

Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis

Anna Glasier, Sharon Cameron, Paul Fine et al. · 2010 · The Lancet · 517 citations

Reading Guide

Foundational Papers

Start with Task Force (1998, 731 citations) for levonorgestrel vs Yuzpe RCT baseline, then von Hertzen et al. (2002, 570 citations) WHO trial on regimens, and Glasier et al. (2010, 517 citations) for ulipristal introduction.

Recent Advances

Curtis et al. (2016, 1442 citations) U.S. MEC for eligibility; Curtis et al. (2016, 755 citations) SPR for practices; Sedgh et al. (2015, 796 citations) for pregnancy trends context.

Core Methods

Randomized controlled trials (RCTs) with pregnancy rates as endpoints (Task Force 1998; Glasier 2010); multicentre designs (von Hertzen 2002); meta-analyses and U.S. guideline syntheses (Curtis 2016).

How PapersFlow Helps You Research Emergency Contraception Effectiveness

Discover & Search

Research Agent uses searchPapers and exaSearch to find Glasier et al. (2010) on ulipristal vs levonorgestrel, then citationGraph reveals von Hertzen et al. (2002) WHO trial connections and findSimilarPapers uncovers Curtis et al. (2016) guidelines.

Analyze & Verify

Analysis Agent applies readPaperContent to extract efficacy rates from Task Force (1998), verifyResponse with CoVe for timing claims, and runPythonAnalysis for meta-analysis of BMI effects using GRADE grading on RCTs like Glasier et al. (2010). Statistical verification confirms 85-95% pregnancy reduction.

Synthesize & Write

Synthesis Agent detects gaps in BMI data across Curtis (2016) and Glasier (2010), flags contradictions in adherence (Wellings et al., 2013), then Writing Agent uses latexEditText, latexSyncCitations, and latexCompile for review manuscripts with exportMermaid for regimen comparison diagrams.

Use Cases

"Compare levonorgestrel BMI efficacy from recent trials"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-regression on Curtis 2016, Glasier 2010) → CSV export of odds ratios and GRADE scores.

"Draft LaTeX review on ulipristal timing advantages"

Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Glasier 2010, von Hertzen 2002) → latexCompile → PDF with efficacy timeline figure.

"Find analysis code for emergency contraception RCTs"

Research Agent → paperExtractUrls (Glasier 2010) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for survival analysis of timing data.

Automated Workflows

Deep Research workflow conducts systematic review: searchPapers on 50+ papers → citationGraph clustering Curtis (2016) family → DeepScan 7-step verification with CoVe on efficacy claims → structured report on regimens. Theorizer generates hypotheses on BMI mechanisms from von Hertzen (2002) and Glasier (2010) via literature synthesis.

Frequently Asked Questions

What defines emergency contraception effectiveness?

It measures pregnancy prevention rates post-unprotected sex using levonorgestrel (1.5mg) or ulipristal (30mg), with 72-120 hour windows (Glasier et al., 2010; Task Force, 1998).

What are key methods studied?

RCTs compare levonorgestrel vs Yuzpe (Task Force, 1998, 731 citations), low-dose variants (von Hertzen et al., 2002), and ulipristal non-inferiority trials (Glasier et al., 2010).

What are seminal papers?

Task Force (1998, 731 citations) established levonorgestrel superiority; Glasier et al. (2010, 517 citations) proved ulipristal efficacy; Curtis et al. (2016, 1442 citations) set U.S. guidelines.

What open problems remain?

BMI-adjusted dosing lacks large trials; real-world adherence gaps persist (Wellings et al., 2013); ovulation inhibition needs advanced modeling beyond current RCTs.

Research Reproductive Health and Contraception with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Emergency Contraception Effectiveness with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers